Primary care physicians are uniquely placed to offer holistic, patient-centred care to patients with T2DM. While the recent FDA-mandated cardiovascular outcome trials offer a wealth of data to inform treatment discussions, they have also contributed to increasing complexity in treatment decisions, and in the guidelines that seek to assist in making these decisions. To assist physicians in avoiding treatment inertia, Primary Care Diabetes Europe has formulated a position statement that summarises our current understanding of the available T2DM treatment options in various patient populations. New data from recent outcomes trials is contextualised and summarised for the primary care physician. This consensus paper also proposes a unique and simple tool to stratify patients into ‘very high’ and ‘high’ cardiovascular risk categories and outlines treatment recommendations for patients with atherosclerotic cardiovascular disease, heart failure and chronic kidney disease. Special consideration is given to elderly/frail patients and those with obesity. A visual patient assessment tool is provided, and a comprehensive set of prescribing tips is presented for all available classes of glucose-lowering therapies. This position statement will complement the already available, often specialist-focused, T2DM treatment guidelines and provide greater direction in how the wealth of outcome trial data can be applied to everyday practice.

初级保健医生的位置独特，可以为T2DM患者提供以患者为中心的整体护理。尽管最近FDA要求的心血管结果试验提供了大量数据来为治疗讨论提供信息，但它们也有助于增加治疗决策以及寻求帮助做出这些决策的指南中的复杂性。为了帮助医生避免治疗惯性，欧洲初级保健糖尿病组织制定了一份立场声明，总结了我们对各种患者群体中可用的T2DM治疗方案的当前理解。最近的结果试验中的新数据将根据基层医生的情况进行总结和总结。该共识性文件还提出了一种独特而简单的工具，可将患者分为“非常高”和“高度”的心血管风险类别，并概述了对动脉粥样硬化性心血管疾病，心力衰竭和慢性肾脏病患者的治疗建议。特别考虑老年/体弱患者和肥胖者。提供了一种可视的患者评估工具，并针对所有可用的降糖疗法类别提供了一套完整的处方提示。该立场声明将补充已经可用的，通常以专家为重点的T2DM治疗指南，并为如何将大量结果试验数据应用于日常实践提供更大的指导。心力衰竭和慢性肾脏疾病。特别考虑老年/体弱患者和肥胖者。提供了一种可视的患者评估工具，并针对所有可用的降糖疗法类别提供了一套完整的处方提示。该立场声明将补充已经可用的，通常以专家为重点的T2DM治疗指南，并为如何将大量结果试验数据应用于日常实践提供更大的指导。心力衰竭和慢性肾脏疾病。特别考虑老年/体弱患者和肥胖者。提供了一种可视的患者评估工具，并针对所有可用的降糖疗法类别提供了一套完整的处方提示。该立场声明将补充已经可用的，通常以专家为重点的T2DM治疗指南，并为如何将大量结果试验数据应用于日常实践提供更大的指导。